The TEVAR Center

Filter Your Results




Relay®Plus Subset Analysis From the United States FDA Phase 2 Clinical Trial

Marvin D. Atkins, MD; Prashanth Vallabhajosyula, MD, MS; and Wilson Y. Szeto, MD

February 2018—Midterm results of the Bolton Relay® Thoracic Stent Graft with an emphasis on improvements to the delivery system.

Terumo Invests £33 Million Into Vascutek Expansion

February 12, 2018 -- Terumo Corporation has announced a £33 million investment into subsidiary Vascutek Ltd. with a goal of driving further growth for the Scotland-based…

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

AHA Announces Strategically Focused Research Network for Vascular Disease

January 16, 2018 -- The American Heart Association (AHA) recently announced that scientific teams have been selected that will lead a new AHA-funded research network dedicated…

French WINDOW Trial Investigators Evaluate Cost-Effectiveness of Fenestrated/Branched EVAR for Complex Aortic Aneurysms

January 16, 2018 -- Two-year results from a study of the cost-effectiveness of fenestrated/branched endovascular aneurysm repair (f/b EVAR) compared with open surgical repair …

Study Suggests Anatomic Criteria to Determine Appropriateness of TEVAR in Uncomplicated Type B Aortic Dissection

January 8, 2018 -- The Society for Vascular Surgery (SVS) announced the publication of findings that suggest thoracic endovascular aortic repair (TEVAR) may be appropriate in …

Cook's t-Branch Device Evaluated for EVAR of Acute TAAA

December 13, 2017 -- The outcomes of endovascular aneurysm repair (EVAR) for acute thoracoabdominal aortic aneurysms (TAAAs) and the applicability of the off-the-shelf (OTS) Z…

Enrollment Begins in Trial of Bolton Medical's RelayPro for Treatment of Blunt Traumatic Aortic Injury

December 5, 2017 -- Bolton Medical, Inc. announced that the first patient has been enrolled in the US Food and Drug Administration phase 2 clinical trial of the company's …




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.